Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3734_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
Long-Term Imaging oftheAorta: Considerations andComparison ofModalities
https://t.me/med1917
imaging surveillance in the acute phase given its superior spatial resolution and better ability to detect mediastinal/periaortic soft tissue abnormalities associated with leak/contained rupture, magnetic resonance angiography (MRA) is a reason­able alternative for long-term annual imaging surveillance of patients with stable and uncomplicated dissections, and avoids the cumulative risk of repeated radia­tion exposure.
191
Intramural Hematoma (IMH) andPenetrating Atherosclerotic Ulcer (PAU)
Published recommendations for imaging surveillance of patients with IMH and PAU largely mirror those for patients with aortic dissection, although data on long­term imaging are even more limited than for dissection. Frequent imaging follow­up in the early phase is of particular importance to patients with IMH, as the majority of the complications occur within the rst year, and patients with non­resolving IMH have been shown to be at the greatest risk [7]. In addition to maxi­mal aortic dimeter of the affected segment, the degree of mural thickness should be assessed to track IMH evolution. PAUs are occasionally incidentally detected in asymptomatic patients, and in this setting annual imaging surveillance is generally performed. While many PAUs can be managed non-operatively, lesions that are painful or associated with other complications such as intramural hematoma, pseu­doaneurysm or signs of rupture, open or endovascular repair may be necessary [8,
9]. Long-term imaging follow-up is important in PAUs as approximately 43% of
symptomatic PAUs and 16% of asymptomatic PAUs were noted to progress on follow-up imaging [10]. Although specic imaging surveillance recommendations are not supported by strong evidence and are subject to signicant variability, a general summary of standard imaging follow-up intervals in several clinical sce­narios is presented in Table1.
Comparison ofImaging Modalities
The three primary imaging modalities for long-term monitoring and follow-up imaging in the thoracic aorta are CT angiography (CTA), MR angiography (MRA), and echocardiography. Each modality has strengths and weaknesses for imaging the thoracic aorta. The selection of the appropriate imaging test should be driven by specic aortic pathology, surgical history, co-morbidities such as aortic valve dis­ease or extension of dissection or aneurysm into the abdominal aorta, and patient related factors, particularly renal function and age.
192
N. S. Burris et al.
https://t.me/med1917
Table 1 Summary of standard imaging surveillance intervals
Clinical Scenario Early Follow-Up (0–12months)
Aortic dissection
Type A (repaired)
Type B (OMT)
Post­Endograft
IMH/PAU Before discharge and @1 month*
† Consider MRI/MRA if appropriate for patient-specic factors ‡ Addition of delayed phase imaging is recommended
a
CTA is preferred modality Abbreviations: OMT optimal medical therapy, IMH intramural hematoma, PAU penetrating ath­erosclerotic ulcer, ULP ulcerlike projection
Before discharge or @1 month*
– If enlarging: 3, 6 & 12months* – If stable: 6 & 12months
Before discharge and @1 month*
– If enlarging: 3, 6 & 12months* – If stable: 6 & 12months
Before discharge or @1 month*‡ – If enlarging and/or signicant endoleak: 3, 6 & 12months*‡
– If stable/no endoleak: 6 & 12months
– If non-resolving: 3, 6 & 12months* – If resolving: 6 & 12months
Recommend careful image analysis for development of intimomedial defects or ULP [11]
Long-Term Follow-up (12months +)
If stable: Annual intervals† If enlarging: 6month intervals
– After ≥3years stability, consider change to 2 or 3year intervals†.
If stable: Annual intervals† If enlarging: 6month intervals
– After ≥3years stability, consider change to 2year intervals†.
If stable/FL regression: Annual intervals†
If enlarging: 6month intervals After 3years stability,
consider change to 2 or 3year intervals†.
In the absence of indications for repair: If non-resolving IMH: 6–12months intervals If resolved IMH: – Annual intervals if residual aortic dilation† – Unclear role of continued imaging if no residual aortic dilation
Echocardiography Versus Cross-Sectional Imaging
While echocardiography is not the preferred modality for comprehensive thoracic aorta evaluation, all standard echocardiography examinations can provide informa­tion on multiple aortic segments and it has been recommended as a primary screen­ing tool in aortic disease. The aortic valve, sinuses and proximal ascending aorta can usually be well assessed with transthoracic echocardiography (TTE), while evalua­tion of the descending aorta requires transesophageal echo for evaluation (TEE). On TTE, using a combination of left and right parasternal long axis views and basal short axis views, it is possible to measure the aortic annulus, sinuses of Valsalva (SOV), and sinotubular junction (STJ). Right parasternal and apical long axis views
Long-Term Imaging oftheAorta: Considerations andComparison ofModalities
https://t.me/med1917
are used to measure ascending aorta diameters (AAo). Suprasternal views allow visualization of the aortic arch and branch vessels although this sonographic win­dow can be limited due to patient body habitus or emphysema. TEE allows for short- and long-axis evaluation of the descending aorta, but the invasive nature of this test limits its usefulness as a standard follow-up or monitoring tool [12].
An important advantage of the TTE compared to other cross-sectional modalities is the relative ease of acquisition without the need for intravenous contrast or expo­sure to ionizing radiation. This feature makes TTE a useful tool in serial monitoring post-operative complications following ascending aorta repair. Additional key advantages of echocardiography for aortic evaluation include the opportunity to assess any co-morbid aortic valve disease and measure biophysical properties such as aortic distensibility and pulse wave velocity with Doppler echocardiography [13]. For follow-up imaging in ascending aortic disease, an important disadvantage of TTE is that aortic diameters are measured only in the long-axis plane, and this approach has been shown to underestimate aortic diameter when compared to double- oblique measurements [14]. While there are several possible measurement techniques, the “leading edge to leading edge” technique has been shown to have excellent reproducibility and the best agreement with CTA measurements [15].
193
CTA Acquisition
CT Angiography is considered the primary imaging modality for diagnosing and monitoring thoracic aorta disease and for follow-up imaging after aortic interven­tions. Key advantages of CTA are that image acquisition is fast, less complex than MRI/MRA and yields high resolution images. CTA is generally performed with spatial resolutions on the order of 0.7mm3, and its volumetric nature allows for 3D analysis and multi-planar reformats of aortic anatomy. Depending on scanner spe­cic features such as detector size, CTA acquisitions of the chest can be performed in a single breath-hold of 5–10seconds, with some modern scanners in 1–2seconds [16]. An important disadvantage of CTA is that the exam most often provides static snapshot of the anatomy and lacks hemodynamic information. CTA can generate dynamic “cine” images with the use of retrospective electrocardiograph (ECG) gat­ing techniques, however, this comes at the cost of higher radiation dose and should thus be used sparingly.
CTA requires intravenous injection of iodinated contrast with timing of image acquisition such that aortic opacication is maximal. Poor contrast timing can sig­nicantly limit the diagnostic performance of the test. Patients are generally asked to hold their breath during the scan to minimize respiratory motion. For evaluation of aortic root size or ascending aorta diameter, ECG gating is usually employed. ECG-gating limits cardiac and aortic root motion to decrease motion-related arti­facts which can result in inaccurate measurements and limit the assessment of the dissection aps. Prospective ECG gating involves only acquiring images during a portion of the cardiac cycle, most often in mid-late diastole (70–75% R-R interval),
194
https://t.me/med1917
and this approach requires signicantly less radiation than retrospective gating. ECG-gating can fail in the setting of arrhythmia due to inconsistent R-R intervals resulting in motion/pulsation artifact. ECG-gating is generally not required for eval­uation of the arch and descending aorta where pulsatile motion is less pronounced.
N. S. Burris et al.
MRI/MRA Acquisition
MR angiography has similar spatial resolution to CTA, usually in the range of
0.7–1.2mm3, but patient related factors such as body habitus may necessitate chang­ing the eld of view which can lower image resolution. Scan times for MRA tend to be longer, usually due to the acquisition of multiple sequences during each study. However, MRA offers several advantages relative to CTA including lack of ionizing radiation, opportunity to acquire hemodynamic information through time-resolved techniques, and ability to evaluate luminal/intraluminal structures with non-contrast MRA techniques.
Similar to CTA, contrast-enhanced MRA (CE-MRA) acquisition requires image acquisition timing to be optimized to contrast opacication of the aorta. The CE-MRA technique employs a 3D T1 weighted sequence which leverages the T1 shortening properties of gadolinium—rather than the x-ray attenuating properties of iodine—to provide high contrast within the aortic lumen. Similar to CTA, MRA of the aorta is ECG-gated to reduce artifacts at the root and ascending aorta due to cardiac motion. Breath-holding is also necessary at MRA to limit respiratory motion artifact. In addition to CE-MRA images, most studies will include pre- and/or post­contrast T1 and T2 weighted sequences, which can help with identication of intra­mural hematoma, mediastinal abnormalities, and vessel wall inammation [17].
Multiple non-contrast MRA techniques have been developed that can be useful in patients where contrast imaging is either limited or not possible. Steady-state free precession (SSFP) is an MR acquisition technique which results in high signal intensity of the blood without the need for intravenous contrast. Three-dimensional, ECG-gated, non-contrast SSFP MRA provides excellent image quality and accurate aorta measurements relative to CE-MRA, but requires signicantly longer scan times [18, 19]. Other options for non-contrast assessment of the thoracic aorta include spin-echo, time-of-ight (TOF), and phase contrast techniques.
MRI/MRA also provides the ability to evaluate aortic hemodynamics using time­resolved MRA (TR-MRA), as well as two-dimensional and three-dimensional (“4D Flow”) phase contrast techniques (Fig. 1). Time-resolved MRA is a contrast­enhanced technique which acquires images rapidly during contrast injection yield­ing dynamic images of contrast transit similar to angiography, and can provide information such as the location of endoleaks after TEVAR and false lumen lling patterns in aortic dissection. Phase-contrast MRA can be used as a non-contrast technique which measures differences in magnetic spin phase shifts that occur with owing blood. These phase shifts are proportional to ow velocity, thus allowing for quantication of aortic blood velocity and ow rates. This technique can be
Long-Term Imaging oftheAorta: Considerations andComparison ofModalities
https://t.me/med1917
195
abc
Fig. 1 Anatomic Versus Hemodynamic Assessment with Computed Tomography Angiography (CTA) and Magnetic Resonance Angiography (MRA): Sagittal view of a patient with TBAD using
CTA (a) demonstrates a proximal entry tear (arrow head) and distinct true and false lumen. Similarly, sagittal MRA images also clearly depict the entry tear with similar anatomic detail to CTA (b). MRI also allows for measurement of blood ow velocity, and three-dimensional maps of blood ow can be generated using 4D Flow MRI techniques, allowing for clear visualization of the ow jet at the proximal entry tear (c), which impacts the opposite wall of the false lumen (asterisk)
applied in 2D or 3D and has been used to assess valve-related aortopathy, pulse­wave velocity and many other advance hemodynamic parameters [20].
Artifacts andTechnical Limitations
Several imaging related artifacts can limit CTA image quality. One of the most com­monly encountered CT artifacts is beam-hardening or “streak” artifact which results from dense structures (bones, surgical implants, wires, pacemaker/debrillator gen­erators, iodinated contrast in the superior vena cava) interfering with normal image formation [21]. Newer dual-energy CT scanners have metal artifact reduction algo­rithms which can be employed to reduce the impact of such artifacts [22]. To image the entire chest with CTA, the CT table must translate during the scan, and with ECG-gating this can mean different portions of the chest are imaged at different R-R intervals. Motion during imaging can lead to a linear “step-off” or “stair step” artifact, which is most visible on coronal or sagittal reformatted series. Such step­offs can blur the aortic wall, lead to inaccurate aortic measurements and be mistaken for dissection (Fig.2) [23].
With MRA, distortions in the magnetic eld caused by metallic objects in the body often can produce susceptibility artifact, which present as areas of dark sig­nal void surrounding the metallic object and are worse in 3T compared to 1.5T scanners. Potential sources of artifact include pacemaker/ICD generators or elec­trodes, spinal hardware, and sternal wires. Endografts composed of nitinol can be imaged with MRI/MRA, whereas stainless-steel endografts result signicant
196
ab
https://t.me/med1917
Fig. 2 Motion/pulsation artifact on non-ECG gated CT scans can result in blurring of the margins of the aorta and main pulmonary artery (a, arrow head) and image artifacts that simulate aortic dissection. In this representative case, a dissection ap in the ascending aorta (a, arrow) was described at an outside hospital CT performed without ECG-gating, however, on repeat CT scan with ECG-gating the ap was conrmed to be artifactual in nature (b)
N. S. Burris et al.
artifacts and are poorly evaluated [24]. Patient specic factors can degrade image quality, with the most important factors being arrhythmia (failure of ECG-gating), difculty with breath holding, and claustrophobia. Claustrophobia and breath­holding difculties tend to be more severe in MRA than CTA due to longer image acquisition times, a longer scanner bore, and need for multiple breath-holds during the exam.
CTA Radiation Exposure
Radiation exposure if a common concern of patients and physicians, and it is well documented that ionizing radiation is associated with a risk of malignancy, particu­larly in radiosensitive organs in the chest such as the breasts, lungs, and thyroid. Estimates of cancer risks due to radiation doses below 100 millisievert (mSv), a dose corresponding to approximately 1000 chest radiographs or 10 CTAs, are not well validated but are estimated at approximately 1% lifetime risk [25]. As scanner technology and imaging processing algorithms have improved, CT doses have dra­matically decreased. Currently, an ECG-gated CTA of the chest has an effective radiation dose of ~5–8mSv. In most patients with thoracic aortic disease, the benet of undergoing optimal imaging far outweighs the risk of radiation-induced malig­nancy. Considering the typical latency period of 10 years, the signicance of radiation- induced malignancy should be considered in the context of patient life expectancy [26]. However, children, younger adults and pregnant patients exposed to similar doses of radiation have a considerably higher risk, and alternative imag­ing strategies should be considered in these groups [27].
Long-Term Imaging oftheAorta: Considerations andComparison ofModalities
https://t.me/med1917
197
Contrast Safety Concerns
Both iodinated contrast for CTA and gadolinium contrast for MRA have patient safety concerns that may determine which modality is should be considered when selecting the best imaging modality for a given patient. Iodinated contrast has his­torically been associated with acute kidney injury, a phenomenon termed contrast induced nephropathy (CIN), with guidelines suggesting reduced contrast dose or the withholding contrast in patients with renal insufciency to reduce the risk of renal failure in these patients. Increasingly, data has suggested that the risk of CIN, even in patients with GFR<30mL/min is very low or possibly non-existent [28]. Institutional guidelines should be reviewed to determine the locally accepted iodin­ated contrast dosing practice.
Gadolinium-related nephrogenic systemic brosis (NSF) has been a concern in patients with low renal function (GFR < 30 ml/min) undergoing contrast­enhanced MRI/MRA. However, gadolinium-based contrast agents have now been developed with safety proles which make the likelihood of NSF exceed­ingly low and routinely checking renal function prior to contrast enhanced MRI is not required in most patients [29]. Over the last several years there has been increasing evidence of MRI-related gadolinium deposition in the brain and other organs. While the signicance of this nding remains uncertain and no clear clinical sequela have been identied, it is a dose dependent phenomenon, and therefore patients undergoing frequent MR studies, particularly younger patients, should carefully consider the potential risks and benets of contrast administra­tion [30]. This phenomenon may increase the importance of non-contrast MRA techniques in the future. The strengths and limitations of CTA and MRA are summarized in Table2.
Post-Endograft Imaging
Imaging Follow-Up
There are no standardized guidelines for imaging follow-up of patients after endo­vascular repair of aortic dissection or other acute aortic syndromes, partly owing to the wide degree of variability in repair complexity and the rapidly evolving nature of endovascular techniques. However, there are some principles of post-endograft surveillance that are widely accepted and have been summarized in recently pub­lished appropriateness criteria [31]. CTA is generally considered the optimal modal­ity for imaging surveillance, at least within the rst 6–12months after repair, given the superior imaging resolution, ability to evaluate the integrity of metallic stent frames, and improved evaluation for potential mediastinal or other intra-thoracic complications. Assessment of aortic remodeling after TEVAR is most commonly performed by aortic diameter measurement (either overall diameter or false lumen
198
https://t.me/med1917
Table 2 Comparing CTA and MRI
Characteristic CT Angiography (CTA) MR Angiography (MRA)
Radiation Ionizing radiation (X-ray)
Spatial resolution 0.5mm Number of
acquisitions Set-up and scan
time Acquisition
complexity Patient
participation
Strength Anatomy Soft tissue characterization and
Contrast risk Iodinated contrast:
– DNA damage
3
(minimal) ~ 0.7–1.2mm3 (variable)
Usually single Usually multiple
Short (5–10min) Long (45–60min)
Easy More difcult
Minimal – Single breath hold – Hold still for ~10–30seconds
1. Contrast-induced nephropathy (CIN) – Rare
2. Severe allergy (~1:1000)
Non-ionizing (radiofrequency) – No DNA damage
Signicant—Multiple breath hold – Multiple breath holds – Hold still for at least 5–10minutes
hemodynamic/functional assessment
Gadolinium contrast:
1. Nephrogenic systemic brosis (NSF) – Extremely rare
2. Gadolinium deposition in brain (unclear signicance)
2. Severe allergy (~1:100,000)
N. S. Burris et al.
diameter). False lumen volumetric assessment has been proposed as a more sensi­tive marker of false lumen remodeling in a variety of studies and trials, and while there are clear theoretical benets of volumetric measurements, such measurement techniques remain poorly standardized and the benet over diameter measurements has not been formally established [32].
Imaging surveillance in the post-endograft generally involves the rst post­operative study being performed before discharge or at least within the rst month, with subsequent studies typically occurring at 3–6 and 12 months and annually thereafter in the absence of growth or other complications. Long-term follow-up studies of TEVAR patients have shown that late complications can occur (e.g. devel­opment of endoleaks, stent fracture, stent graft migration), and lifelong imaging surveillance of patients with aortic endografts is therefore recommended [33]. Imaging protocols for CTA/MRA vary by institution, however, generally post­endograft studies are performed with multiple phases of contrast including noncon­trast, arterial phase and delayed phase (30–60seconds after arterial phase) (Fig.3). Delayed phase imaging is a unique feature of post-endograft studies, and is neces­sary for the detection of low ow endoleaks [34].
Long-Term Imaging oftheAorta: Considerations andComparison ofModalities
https://t.me/med1917
199
abc
Fig. 3 Post-Endograft CTA Technique: Standard post-endograft CTA consists of a 3-phase imag- ing protocol. First, a non-contrast scan is performed (a) to clearly identify any dense objects such as the metallic endograft, surgical material (asterisk) or calcium (arrowhead). Second, contrast is administered and images are acquired in the early arterial phase (b), producing maximal aortic opacication and allowing identication of endoleaks (arrow). Lastly, a delayed phase is acquired (30–60seconds after arterial phase) to allow detection of slow lling endoleaks and better depict the full extent of any endoleaks (arrowhead)
Patient-Specic Considerations forPost-Endograft Imaging Surveillance
Two common patient-specic considerations that arise with post-endograft imaging surveillance are the cumulative radiation exposure of CT among young patients (<50–60), particularly those with connective tissue disease or traumatic aortic injury, and contrast-induced nephropathy among patients with renal insufciency. Both of these situations can often be managed effectively by utilizing noncontrast imaging, MRI/MRA or a combination of both. Studies have shown that cumulative radiation doses accrued during post-endograft CT imaging surveillance can often reach the level of 350 mSieverts, a level at which the estimated rate of radiation­induced malignancy would be 2.5% [35]. Radiation concerns are less over 65–70years of age or when the expected lifespan is less than 10–15years, given the latency period of radiation-induced malignancy. Options to limit radiation dose include limiting the number of phases acquired (e.g. noncontrast phase if already acquired in prior studies) or utilizing MRI/MRA techniques, which do not utilize employ ionizing radiation. Magnetic artifact prevents MR imaging of stainless steel endografts, however, newer nitinol endografts do not produce signicant artifact and can be adequately assessed with MRI/MRA (Fig.4) [36]. In the setting of renal insufciency, noncontrast CT imaging can be performed to assess the overall aortic dimensions and device stability/integrity, although assessment of endoleaks and individual lumen dimensions and intraluminal pathology is not possible. Noncontrast
200
ab
https://t.me/med1917
N. S. Burris et al.
Fig. 4 Post-Endograft Surveillance with MRA: Sagittal images of a patient with penetrating ath- erosclerotic ulcer of the descending aorta who underwent TEVAR using a nitinol endograft. The metallic endograft can be clearly seen on CTA images (a, arrow head). While the endograft mate­rial appears dark/black on MRA images (b), the nitinol doesn’t create any signicant artifact in the image and detailed evaluation of the lumen and surrounding anatomy is possible
MRI/MRA techniques have the unique ability to delineate blood, thrombus and the aortic wall, and can thus be a powerful tool for long-term imaging surveillance for patients with nitinol-based endografts.
Post-Processing andMeasurement
Measurement Techniques andLimitations
Maximal aortic diameter is the primary metric of aortic disease severity, and is mea­sured in imaging surveillance to monitor disease progression, estimate risk of com­plications and to determine surgical candidacy [37]. While aortic diameter is simple to measure and has a well-dened biomechanical relationship with wall tension (i.e., Laplace’s law), accurate and reproducible diameter measurements can be chal­lenging for technical and anatomic reasons. Traditionally aortic diameter measure­ments were performed on axial CT images; however, it is well-recognized that this